Paweł Szymański (Pawel Szymanski)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 28

Top Venues

International journal of molecular sciences

Healthcare (Basel, Switzerland)

Archiv der Pharmazie

Molecules (Basel, Switzerland)

Medical University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Medical University Oct 01 2006

Poland

prof :: Department of Pharmaceutical Chemistry, Drug Analysis and Radiopharmacy

Publications

Magdalena Zawadzka, Aleksandra Lis, Justyna Marszałkowska-Jakubik, Paweł Szymański
Evaluation of Soldiers' Knowledge and Sense of Threats Regarding Exposure to Biological Risk Factors at the Place of Service. Healthcare (Basel, Switzerland) 12 (17) (2024)
Karolina Maciejewska-Stupska, Kamila Czarnecka, Paweł Szymański
Bioavailability enhancement of coenzyme Q 10 : An update of novel approaches. Archiv der Pharmazie (2024)
Karolina Maciejewska-Stupska, Kamila Czarnecka, Paweł Szymański
Bioavailability enhancement of coenzyme Q 10 : An update of novel approaches. Archiv der Pharmazie 357 (8) (2024)
Ewelina Ejchman-Pac, Małgorzata Rzepka, Małgorzata Gierlach, Paweł Szymański, Magdalena Zawadzka
Evaluation of Knowledge and Self-Awareness of Polish Soldiers Regarding Exposure to Chemical and Physical Factors in Their Place of Service/Work. Healthcare (Basel, Switzerland) 12 (4) (2024)
Ewelina Ejchman-Pac, Małgorzata Rzepka, Małgorzata Gierlach, Paweł Szymański, Magdalena Zawadzka
Evaluation of Knowledge and Self-Awareness of Polish Soldiers Regarding Exposure to Chemical and Physical Factors in Their Place of Service/Work. Healthcare (Basel, Switzerland) 12 (4) (2024)
Ewelina Ejchman-Pac, Małgorzata Rzepka, Małgorzata Gierlach, Paweł Szymański, Magdalena Zawadzka
Evaluation of Knowledge and Self-Awareness of Polish Soldiers Regarding Exposure to Chemical and Physical Factors in Their Place of Service/Work. Healthcare (Basel, Switzerland) 12 (4) (2024)
Przemysław Koźmiński, Dorota Niedziałek, Grzegorz Wieczorek, Paweł Krzysztof Halik, Kamila Czarnecka, Aleksandra Rogut, Łukasz Cheda, Zbigniew Rogulski, Paweł Szymański, Ewa Gniazdowska
New Imaging Modality of COVID-19 Pneumonia Developed on the Basis of Alzheimer's Disease Research. International journal of molecular sciences 23 (15) (2022)
Agnieszka Czylkowska, Suneel Lanka, Małgorzata Szczesio, Kamila Czarnecka, Paweł Szymański, Monika Pitucha, Aneta Drabinska, Bruno Cury Camargo, Jacek Szczytko
New Derivatives of 5-((1-Methyl-Pyrrol-2-yl) Methyl)-4-(Naphthalen-1-yl)-1,2,4-Triazoline-3-Thione and Its Coordination Compounds with Anticancer Activity. International journal of molecular sciences 23 (16) (2022)
Anita Raducka, Marcin Swiatkowski, Katarzyna Gobis, Paweł Szymański, Agnieszka Czylkowska
In Silico ADME and Toxicity Prediction of Benzimidazole Derivatives and Its Cobalt Coordination Compounds. Synthesis, Characterization and Crystal Structure. Molecules (Basel, Switzerland) 27 (22) (2022)
Małgorzata Krzyżowska, Martyna Janicka, Emilia Tomaszewska, Katarzyna Ranoszek-Soliwoda, Grzegorz Celichowski, Jarosław Grobelny, Paweł Szymański
Lactoferrin-Conjugated Nanoparticles as New Antivirals. Pharmaceutics 14 (9) (2022)
Aneta Kosińska, David Virieux, Jean-Luc Pirat, Kamila Czarnecka, Małgorzata Girek, Paweł Szymański, Sławomir Wojtulewski, Saranya Vasudevan, Arkadiusz Chworos, Bogna Rudolf
Synthesis and Biological Studies of Novel Aminophosphonates and Their Metal Carbonyl Complexes (Fe, Ru). International journal of molecular sciences 23 (15) (2022)
Karolina Maciejewska, Kamila Czarnecka, Paweł Kręcisz, Dorota Niedziałek, Grzegorz Wieczorek, Robert Skibiński, Paweł Szymański
Novel Cyclopentaquinoline and Acridine Analogs as Multifunctional, Potent Drug Candidates in Alzheimer's Disease. International journal of molecular sciences 23 (11) (2022)
Bartłomiej Rogalewicz, Alina Climova, Ekaterina Pivovarova, Jarosław Sukiennik, Kamila Czarnecka, Paweł Szymański, Małgorzata Szczesio, Katarzyna Gas, Maciej Sawicki, Monika Pitucha, Agnieszka Czylkowska
Antitumor Activity and Physicochemical Properties of New Thiosemicarbazide Derivative and Its Co(II), Ni(II), Cu(II), Zn(II) and Cd(II) Complexes. Molecules (Basel, Switzerland) 27 (9) (2022)
Agnieszka Czylkowska, Bartłomiej Rogalewicz, Małgorzata Szczesio, Anita Raducka, Katarzyna Gobis, Paweł Szymański, Kamila Czarnecka, Bruno Cury Camargo, Jacek Szczytko, Alexey Babich, Sergey Dubkov, Dmitrii Pepelayev
Antitumor Activity against A549 Cancer Cells of Three Novel Complexes Supported by Coating with Silver Nanoparticles. International journal of molecular sciences 23 (6) (2022)
Agnieszka Czylkowska, Małgorzata Szczesio, Anita Raducka, Bartłomiej Rogalewicz, Paweł Kręcisz, Kamila Czarnecka, Paweł Szymański, Monika Pitucha, Tomasz Pawlak
Cytotoxic Activity against A549 Human Lung Cancer Cells and ADMET Analysis of New Pyrazole Derivatives. International journal of molecular sciences 22 (13) (2021)
Kamila Czarnecka, Jakub Chuchmacz, Przemysław Wójtowicz, Paweł Szymański
Memantine in neurological disorders - schizophrenia and depression. Journal of molecular medicine (Berlin, Germany) 99 (3) (2021)
Ewa M Nowosielska, Aneta Cheda, Mateusz Pociegiel, Lukasz Cheda, Paweł Szymański, Antoni Wiedlocha
Effects of a Unique Combination of the Whole-Body Low Dose Radiotherapy with Inactivation of Two Immune Checkpoints and/or a Heat Shock Protein on the Transplantable Lung Cancer in Mice. International journal of molecular sciences 22 (12) (2021)
Anita Raducka, Agnieszka Czylkowska, Katarzyna Gobis, Kamila Czarnecka, Paweł Szymański, Marcin Swiatkowski
Characterization of Metal-Bound Benzimidazole Derivatives, Effects on Tumor Cells of Lung Cancer. Materials (Basel, Switzerland) 14 (11) (2021)
Karolina Maciejewska, Kamila Czarnecka, Paweł Szymański
A review of the mechanisms underlying selected comorbidities in Alzheimer's disease. Pharmacological reports : PR 73 (6) (2021)
Kamila Czarnecka, Aleksandra Pilarz, Aleksandra Rogut, Patryk Maj, Joanna Szymańska, Łukasz Olejnik, Paweł Szymański
Aspartame-True or False? Narrative Review of Safety Analysis of General Use in Products. Nutrients 13 (6) (2021)
Kamila Czarnecka, Małgorzata Girek, Przemysław Wójtowicz, Paweł Kręcisz, Robert Skibiński, Jakub Jończyk, Kamil Łątka, Marek Bajda, Anna Walczak, Grzegorz Galita, Jacek Kabziński, Ireneusz Majsterek, Piotr Szymczyk, Paweł Szymański
New Tetrahydroacridine Hybrids with Dichlorobenzoic Acid Moiety Demonstrating Multifunctional Potential for the Treatment of Alzheimer's Disease. International journal of molecular sciences 21 (11) (2020)
Karol Kłosiński, Małgorzata Girek, Kamila Czarnecka, Zbigniew Pasieka, Robert Skibiński, Paweł Szymański
Biological assessment of new tetrahydroacridine derivatives with fluorobenzoic moiety in vitro on A549 and HT-29 cell lines and in vivo on animal model. Human cell 33 (3) (2020)
Paweł Kręcisz, Kamila Czarnecka, Paweł Szymański
Physicochemical evaluation of new tetrahydroacridine and iodobenzoic acid hybrids as the next step in the design of potential drugs for treating Alzheimer's disease. Biomedical chromatography : BMC 34 (10) (2020)
Paweł Kręcisz, Kamila Czarnecka, Leszek Królicki, Elżbieta Mikiciuk-Olasik, Paweł Szymański
Radiolabeled Peptides and Antibodies in Medicine. Bioconjugate chemistry 32 (1) (2020)
Małgorzata Girek, Karol Kłosiński, Bartłomiej Grobelski, Stefania Pizzimenti, Marie Angele Cucci, Martina Daga, Giuseppina Barrera, Zbigniew Pasieka, Kamila Czarnecka, Paweł Szymański
Novel tetrahydroacridine derivatives with iodobenzoic moieties induce G0/G1 cell cycle arrest and apoptosis in A549 non-small lung cancer and HT-29 colorectal cancer cells. Molecular and cellular biochemistry 460 (1-2) (2019)
Kamila Czarnecka, Małgorzata Girek, Paweł Kręcisz, Robert Skibiński, Kamil Łątka, Jakub Jończyk, Marek Bajda, Jacek Kabziński, Ireneusz Majsterek, Piotr Szymczyk, Paweł Szymański
Discovery of New Cyclopentaquinoline Analogues as Multifunctional Agents for the Treatment of Alzheimer's Disease. International journal of molecular sciences 20 (3) (2019)
Nina Chufarova, Kamila Czarnecka, Robert Skibiński, Magda Cuchra, Ireneusz Majsterek, Paweł Szymański
New tacrine-acridine hybrids as promising multifunctional drugs for potential treatment of Alzheimer's disease. Archiv der Pharmazie 351 (7) (2018)
Robert Skibiński, Kamila Czarnecka, Małgorzata Girek, Ireneusz Bilichowski, Nina Chufarova, Elżbieta Mikiciuk-Olasik, Paweł Szymański
Novel tetrahydroacridine derivatives with iodobenzoic acid moiety as multifunctional acetylcholinesterase inhibitors. Chemical biology & drug design 91 (2) (2017)

Paweł Szymański.css-eqlu8i{font-size:small;padding-left:4px;} (Pawel Szymanski)

Publication Activity (10 Years)

Top Topics

Top Venues

Paweł Szymański (Pawel Szymanski)